Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-054180
Filing Date
2021-11-04
Accepted
2021-11-03 21:29:06
Documents
6
Period of Report
2021-10-31

Document Format Files

Seq Description Document Type Size
1 6-K meso-6k_20210929.htm 6-K 24461
2 EX-99.1 meso-ex991_6.htm EX-99.1 204774
3 GRAPHIC gldcneqgghtc000002.jpg GRAPHIC 10298
4 GRAPHIC gldcneqgghtc000001.jpg GRAPHIC 5399
5 GRAPHIC gldcneqgghtc000003.jpg GRAPHIC 4786
6 GRAPHIC go12jlgbsebq000001.jpg GRAPHIC 631
  Complete submission text file 0001564590-21-054180.txt   259979
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 211377666
SIC: 2836 Biological Products, (No Diagnostic Substances)